An additional seven patients did not start radioimmunotherapy due to raised serum transaminases/hepatitis (n = 3), patients’ choice for alternative treatment (n = 3) or no significant intratumoral CD8+ immune cell increase (n = 1). The gene discussed is CD8A; the disease is hepatitis A virus infection.